A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma

Asthma is a chronic respiratory condition that is characterized by reversible airflow obstruction. Interleukin-5 (IL-5) is involved in the pathophysiology of the disease and drugs targeting IL-5 have been studied for years as a possible treatment option for severe asthma. In this review, the authors...

Descripción completa

Detalles Bibliográficos
Autores principales: Agumadu, Vivian C, Ramphul, Kamleshun, Mejias, Stephanie G, Sonaye, Ruhi, Sombans, Shaheen, Lohana, Petras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223665/
https://www.ncbi.nlm.nih.gov/pubmed/30416896
http://dx.doi.org/10.7759/cureus.3216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223665/
https://www.ncbi.nlm.nih.gov/pubmed/30416896
http://dx.doi.org/10.7759/cureus.3216

Ejemplares similares